Top Tweets for #ymabs
Y-mAbs Presents GD2-SADA PRIT Trial in Progress Poster at the Advances in Neuroblastoma Research Meeting $YMAB, #YmAbs, #YmAbsTherapeutics, #YmAbsTx https://t.co/kn8XDLXhHp
🚨 In 2020, #YmAbs promoted #Omburtamab as a game-changer for pediatric cancer. But, by 2022, the #FDA rejected it due to insufficient efficacy data, leading to a 72% stock drop.
Check out the full story and how investors can recover their losses now 👇
https://t.co/1fnKxMuHzx
Y-mAbs Therapeutics: Phase 2 Trial 201 data in relapsed/refractory high-risk neuroblastoma show improved patient outcomes with extended naxitamab therapy $YMAB, #YmAbsTherapeutics, #YmAbs https://t.co/UTyHLt5CzB
#YmAbs Announces #FDA Acceptance of #BiologicsLicenseApplication for #OMBLASTYS® (#Omburtamab) for the Treatment of #Neuroblastoma for Priority Review $YMAB https://t.co/j4oNYOPqzM
In the latest issue of #DrugsofToday, we examine the data of #neuroblastoma treatment with the anti-GD2 monoclonal antibody #naxitamab. (URL)
#YmAbs #drugdevelopment #biotech #pharma
Anna Murzhenko of #YmAbs Therapeutics will participate in the panel on #ChildhoodCancer drug development at this week's CAC2 Annual Summit.
Learn more about the Summit and our program (you can still register, too!):
https://t.co/YOKmwzYyU8
#YmAbs Announces #FDA Clearance of #InvestigationalNewDrug for its #Lutetium177 Labeled #Omburtamab #Antibody $YMAB https://t.co/d0f5DooJqv
Join us on #BehindtheBell🔔to hear more from #YmAbs founder Thomas Gad and CEO Claus Møller on the company's IPO day. $YMAB
🎬https://t.co/dhvNxl8lZ1
We are here with #YmAbs Therapeutics to ring the Closing Bell in honor of its IPO today! Congratulations ‼️ $YMAB
✨VP of Listings @DavidWicks, IPO Execution Officer Jay Heller and Senior Managing Director Jordan Saxe standby for the first trade with #YmAbs.
🧐Did you know? @sloan_kettering / Memorial Sloan Kettering Cancer Center, the world’s largest private cancer institution, is #YmAbs’ scientific collaboration partner & shareholder.🌎 #RewriteTomorrow
⚡️It is our pleasure to welcome #YmAbs to the Nasdaq MarketSite on its IPO day! YmAbs Therapeutics is a clinical stage biotechnology company specialized in developing novel antibody therapeutics to treat cancer.
Last Seen Hashtags on Sotwe
momson((()))*+filter:native_video
Seen from Australia
omegle
Seen from Netherlands
floridakilos
Seen from United States
violetmyers #blacked
Seen from Netherlands
nazillitraveſti
Seen from Turkey
momson() +filter:native_video
nickiitheboss
Seen from Algeria
porn
Seen from Austria
rapekink
Seen from United States
izmitpasif
Seen from Turkey
Most Popular Users
Elon Musk 
@elonmusk
241M followers
Barack Obama
@barackobama
119.2M followers
Cristiano Ronaldo
@cristiano
112M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.1M followers
Rihanna
@rihanna
98M followers
NASA
@nasa
92.2M followers
Justin Bieber
@justinbieber
91.2M followers
KATY PERRY
@katyperry
88.5M followers
Taylor Swift
@taylorswift13
82.4M followers
Lady Gaga
@ladygaga
73.9M followers
Virat Kohli
@imvkohli
71.2M followers
Kim Kardashian
@kimkardashian
70.2M followers
YouTube
@youtube
68.7M followers
Bill Gates
@billgates
64.3M followers
Neymar Jr
@neymarjr
64M followers
The Ellen Show
@theellenshow
62.4M followers
CNN
@cnn
61.8M followers
Selena Gomez
@selenagomez
61.5M followers
X
@x
60.8M followers